Opening Ceremony of the "Pioneer Maker Camp" in the Biopharmaceutical Industry Chain of "Neo Bay"

Date:2024-05-27

1231.jpg

On May 21st ,the "Pioneer Maker Camp" in the biopharmaceutical industry has officially started! Gathering of Elites in Pujiang and focusing on the biopharmaceutical industry Classroom lectures and roundtable discussions Problem diagnosis, enterprise visits, etc Rich course formats Embark on a 3-day journey as a maker.





1234.jpg

123.jpg


Our national strategy in the new world landscape.More leading industry entrepreneurs are needed.On this basis, we need to develop-Excellent enterprises,Leading enterprises,Excellent enterprise.Being able to lead the progress of the science and technology innovation industry,and realizing benchmark status.


At the opening ceremony, Professor He Jiaxun, the Course leader and Executive Dean of Shanghai International School of Chief Technology Officer of East China Normal University, encourage students to actively ask questions.Only with problems can there be progress and innovation.

640 (1).jpg




Q&A

Our company mainly focuses on the scientific research market, and most of our employees are research and development personnel. And now we have found that many large companies are starting to focus on the research and development sector, which has brought us greater pressure and triggered our thinking: is the future to horizontally expand research and development products and increase research and development investment? Or vertically hold onto existing products and continuously expand marketing?

                                                                                                                                      ——Liu Shengfu

General Manager of Shanghai Fuheng Biotechnology Co., Ltd

1234567.jpg

Our company has been providing protein related scientific research and technical services since 2012, with a customer base covering many biopharmaceutical companies, including the Fortune 500. Currently, we have a certain foundation, but it seems that we are always lukewarm. Therefore, my question is: What are the integration points between traditional services and new quality productivity that we are currently doing? How can we move towards new markets in the future?

                                                                                                                                          ——Song Kai

Vice General Manager of Shanghai Huaying Biopharmaceutical Technology Co., Ltd

123456.jpg


I have three questions. Firstly, for entrepreneurial enterprises like ours, where everyone has a different industry background and original corporate culture, how can we address the conflicts that arise during the team integration process? Secondly, the overall innovation of the enterprise needs to be coordinated with the innovation of each position, so how to stimulate the personal vitality of employees? Thirdly, when there is a conflict between innovation and conservatism, each with its own advantages and disadvantages, how should we balance or integrate them?

——Lu Changhua

Application Technology Director of Shanghai Ruijing Biotechnology Co., Ltd


As a bank, the biopharmaceutical industry is one of our three "heart industries" and also our key support target. The problem we encounter is that we recruit many excellent employees every year, but the turnover rate is also high. To solve this problem, what advanced management concepts and methods are worth learning from?

——Zhang Liang

Customer Manager of China Construction Bank Pujiang Branch

12345.jpg

Our company is engaged in the full cycle process of drug research and development, production, and sales, but we do not have our own production line. Currently, it involves entrusted production and entrusted verification work for more than ten companies in six cities. All assets are relatively passive and require deep cooperation and bundling with these companies. For example, production needs to follow their needs and their own products. But if we do physical production ourselves, we will face great pressure in terms of production quality control, productivity and capacity, and production system construction. How should one choose?

——Gu Gui

General Manager of Lingyao Biotechnology (Shanghai) Co., Ltd




In the next three days

Let's learn about new quality productivity and innovative leadership together

Understanding Intellectual Property and Technology Forecasts

Exploring the Frontiers of the Biomedical Industry

Cultivate innovative thinking and methods

Enhance strategic market management capabilities

Strive to become problematic and understand problems

The ultimate pioneer in solving problems in science and technology innovation!